HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
13.14
-0.78 (-5.60%)
May 13, 2025, 4:00 PM - Market closed
HUTCHMED (China) Employees
HUTCHMED (China) had 1,811 employees as of December 31, 2024. The number of employees decreased by 177 or -8.90% compared to the previous year.
Employees
1,811
Change (1Y)
-177
Growth (1Y)
-8.90%
Revenue / Employee
$347,985
Profits / Employee
$20,833
Market Cap
2.38B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
HCM News
- 20 days ago - HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025 - GlobeNewsWire
- 22 days ago - HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China - GlobeNewsWire
- 7 weeks ago - HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma - GlobeNewsWire
- 7 weeks ago - Intended Retirement of Independent Non-executive Directors and changes of composition of board committees - GlobeNewsWire
- 7 weeks ago - HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025 - GlobeNewsWire
- 7 weeks ago - HUTCHMED (China) Limited (HCM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Hutchmed's Oncology Revenue Hits $271.5 Million, Rising 65% On Fruzaqla Strength - Benzinga
- 2 months ago - HUTCHMED Reports 2024 Full Year Results and Provides Business Updates - GlobeNewsWire